Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Arxiv|March 30, 2026
GOLDMARK: Governed Outcome-Linked Diagnostic Model Assessment Reference KitChad Vanderbilt, Gabriele Campanella, Siddharth Singi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Shalabh Suman, Gurnit Atwal, et al.
Cancer Discovery|February 28, 2024
Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing DataMadison Darmofal, Shalabh Suman, Gurnit Atwal, et al.
Cancer Medicine|August 11, 2018
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cellsKaren A Cavassani, Rebecca J Meza, David M Habiel, et al.
The American Journal of Surgical Pathology|June 27, 2024
A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1 -altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1 - amplified Versus GLI1- rearranged TumorsCarla Saoud, Abbas Agaimy, Josephine K Dermawan, et al.
Nutrients|August 29, 2017
Chemopreventive Potential of Ethanolic Extracts of Luobuma Leaves (Apocynum venetum L.) in Androgen Insensitive Prostate CancerSzu-Ping Huang, Tzu-Ming Ho, Chih-Wen Yang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell CarcinomaMohammed Alghamdi, Jie-Fu Chen, Achim Jungbluth, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 24, 2015
Supramolecular nanosubstrate-mediated delivery for reprogramming and transdifferentiation of mammalian cellsShuang Hou, Jin-sil Choi, Kuan-Ju Chen, et al.
Advanced Drug Delivery Reviews|March 20, 2018
NanoVelcro rare-cell assays for detection and characterization of circulating tumor cellsYu Jen Jan, Jie-Fu Chen, Yazhen Zhu, et al.
Familial Cancer|October 10, 2024
MSH6-proficient crypt foci in MSH6 constitutional mismatch repair deficiency: reversion of a frameshifted coding microsatellite to its wild-type sequenceJinru Shia, Francisco Sanchez-Vega, Stanley Cho, et al.
Pageof 5